X4 Pharmaceuticals Inc share price logo

X4 Pharmaceuticals Inc Share Price

NASDAQ: XFOR

Small Cap

$3.32

+0.11

(+3.43%)

Live

as on

X4 Pharmaceuticals Inc Stock Performance

as on September 17, 2025 at 7:37 pm IST

  • Day's Low

    Day's High

    $3.1
    $3.37
    downward going graph

    6.63%

    Downside

    1.51%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.35
    $26.83
    downward going graph

    59.34%

    Downside

    708.10%

    Upside

    downward going graph

X4 Pharmaceuticals Inc share price movements today

Previous Close
$3.21
Open
$3.20
Volume
134.0K
Day's Low - High
$3.1 - $3.37
52 Week Low - High
$1.35 - $26.83

X4 Pharmaceuticals Inc Historical Returns

1 Month Return
+ 12.63 %
3 Month Return
+ 17.15 %
1 Year Return
-84.78 %
3 Year Return
-90.27 %
5 Year Return
-98.49 %

X4 Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check X4 Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$72.1M

EPS (TTM)

-4.0275

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-104.5M

Revenue (TTM)

32.8M

Profit Margin

0.00%

Return On Equity TTM

713200.00%

X4 Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of X4 Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
X4 Pharmaceuticals Inc image
X4 Pharmaceuticals Inc
BUY$72.1M-98.49%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$60.5B252.04%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$39.0BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$100.3B44.17%27.8531.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for X4 Pharmaceuticals Inc Stock including INR - Dollar returns

The X4 Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

X4 Pharmaceuticals Inc investment value today

Current value as on today

₹20,348

Returns

₹79,652

(-79.65%)

Returns from X4 Pharmaceuticals Inc Stock

₹84,250 (-84.25%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on X4 Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for X4 Pharmaceuticals Inc. Average target price of $19.75

X4 Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on X4 Pharmaceuticals Inc.

What analysts predicted

83.19%UPSIDE

Target Price

$19.75

Current Price

$3.32

Analyzed by

12 Analysts

Target

$19.75

X4 Pharmaceuticals Inc target price $19.75, a slight upside of 83.19% compared to current price of $3.32. According to 12 analysts rating.

X4 Pharmaceuticals Inc Stock's Interest Amongst Investors

Investment in X4 Pharmaceuticals Inc Shares on INDmoney has dropped by -36.69% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-36.69% versus previous 30 day period

Search interest for X4 Pharmaceuticals Inc Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-19% versus previous 30 day period

X4 Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
3
-
0
0
1
28
1
Gross Profit
0
0
0
2
0
0
0
1
24
1
Operating Income
-25
-25
-27
-25
-37
71
-34
-35
-9
-26
EBITDA
-22
-54
0
-17
-49
-33
-34
-36
2
-26
Interest Expense
1
1
1
1
1
2
2
2
2
2
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-55
-55
-2
-19
-51
90
-36
-39
0
-25
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-55
-55
-2
-19
-51
90
-36
-39
0
-25
Net Profit Margin
0.00%
0.00%
0.00%
-625.16%
0.00%
16133.75%
-6552.86%
-2776.92%
0.98%
-1304.66%

X4 Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
3
3
3
-
-
-
2
Gross Profit
0
0
3
0
3
-1
-1
-1
1
Operating Income
-24
-36
-45
-51
-59
-85
-87
-107
-36
EBITDA
-20
-31
-45
-51
-59
-84
-87
-107
-27
Interest Expense
2
2
1
2
2
3
3
5
8
Depreciation
-
0
0
0
0
0
0
0
0
Income Before Tax
-22
-33
-43
-52
-61
-88
-93
-101
-37
Income Tax Expense
2
1
3
3
0
0
0
0
0
Net Income
-22
-33
-43
-56
-62
-88
-93
-101
-37
Net Profit Margin
0.00%
0.00%
-1229.17%
-1886.80%
-2071.03%
0.00%
0.00%
0.00%
-1464.61%

X4 Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-55
-2
-19
-51
90
-36
-39
0
-25
Operating Cash Flow
-21
-20
-27
-33
-30
-34
-32
-12
-29
Investing Cash Flow
-4
-5
-4
-5
96
-15
-8
-3
23
Financing Cash Flow
69
21
0
-
20
-
0
-
5
Change in Cash
43
-4
-32
-38
86
-49
-41
-15
-1

X4 Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-22
-33
-43
-52
-62
-88
-93
-101
-37
Operating Cash Flow
-21
-27
-40
-48
-58
-70
-77
-96
-130
Investing Cash Flow
0
0
0
27
-1
0
0
-14
66
Financing Cash Flow
18
101
-4
140
12
74
117
88
20
Change in Cash
-3
73
-45
119
-47
2
39
-22
-43

Global Institutional Holdings in X4 Pharmaceuticals Inc

Funds
Holdings
Rhumbline Advisers
0.09%
SG Americas Securities, LLC
0.04%
T. Rowe Price Associates, Inc.
0.04%
Wealth Enhancement Advisory Services, LLC
0.02%
Ronald Blue Trust, Inc.
0%
See all

Insights on X4 Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 152.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 206.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, XFOR stock has moved down by -5.3%

About X4 Pharmaceuticals Inc

x4 pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking and reverse immune suppression, which is fundamental to treating cancer and certain rare, genetic primary immunodeficiency diseases. our oral, small molecule drug candidates inhibit the binding of chemokine cxcl12 to c-x-c receptor type 4 (cxcr4), a receptor-ligand pair that plays an essential role in normal immune surveillance. we are committed to advancing the fields of cancer immunotherapy and genetic immune disorders through innovation and investment in our proprietary clinical and preclinical pipeline. x4’s most advanced product candidate, x4p-001-rd, is in a phase 2/3 study in patients with whim syndrome, a rare genetic, primary immunodeficiency disease. x4p-001-io is currently under investigation in multiple phase 1/2 studies in refractory clear cell renal cell carcinoma (ccrcc) and melanoma. our third program, x4p-002, is in preclinical development and designed specifically for the t
OrganisationX4 Pharmaceuticals Inc
Headquarters61 North Beacon Street, Boston, MA, United States, 02134
IndustryBiotechnology
CEOMr. Mark Baldry M.B.A.
E-voting on sharesClick here to vote

Key Management of X4 Pharmaceuticals Inc

Name

Title

Mr. Mark Baldry M.B.A.

Chief Commercial Officer

Mr. John P. Volpone

President

Dr. Keith T. Flaherty M.D.

Founder & Member of Corporate Advisory Board

Dr. Adam R. Craig M.B.A., M.D., Ph.D.

Executive Chair

Dr. Richard Peters M.D., Ph.D.

Founder

Dr. Renato T. Skerlj Ph.D.

Founder

Mr. David H. Kirske

Chief Financial Officer

Dr. Mary DiBiase Ph.D.

Chief Operating Officer

Ms. Natasha Thoren Esq.

Chief Legal & Compliance Officer

Dr. Christophe Arbet-Engels M.B.A., M.D., Ph.D.

Chief Medical Officer

FAQs

What is X4 Pharmaceuticals Inc share price today?

X4 Pharmaceuticals Inc share price today is $3.32 as on . X4 Pharmaceuticals Inc share today touched a day high of $3.37 and a low of $3.1.

What is the 52 week high and 52 week low for X4 Pharmaceuticals Inc share?

X4 Pharmaceuticals Inc share touched a 52 week high of $26.83 on and a 52 week low of $1.35 on . X4 Pharmaceuticals Inc stock price today i.e. is trending at $3.32,which is 87.63% down from its 52 week high and 145.93% up from its 52 week low.

What is X4 Pharmaceuticals Inc's market capitalisation today?

X4 Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in X4 Pharmaceuticals Inc Stock (XFOR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for X4 Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in X4 Pharmaceuticals Inc Shares that will get you 0.4518 shares as per X4 Pharmaceuticals Inc share price of $3.32 per share as on September 17, 2025 at 7:37 pm IST.

What is the minimum amount required to buy X4 Pharmaceuticals Inc Stock (XFOR) from India?

Indian investors can start investing in X4 Pharmaceuticals Inc (XFOR) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in X4 Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on X4 Pharmaceuticals Inc share’s latest price of $3.32 as on September 17, 2025 at 7:37 pm IST, you will get 3.0120 shares of X4 Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that X4 Pharmaceuticals Inc has given to Indian investors in the last 5 years?

X4 Pharmaceuticals Inc stock has given -98.49% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?